CDC Oct. 22 webinar on COVID-19 and patients with substance use disorder
The Centers for Disease Control and Prevention Oct. 22 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on improving clinicians’ understanding the relationship between COVID-19 and the concerns of people who use drugs or who have a substance use disorder.
Subject matter experts also will highlight existing resources and exceptions for clinicians who prescribe medications for opioid use disorder, existing community-based linkages to care resources and the outpatient telemedicine experience from the perspective of front-line providers. Join the webinar here using ID 160 928 8166. A recording will be available for viewing on the COCA Call webpage a few hours after the live event concludes.
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
President Biden March 13 announced the White House Challenge to Save Lives from Overdose, a national call to action for the public and private sectors to…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Released during National Eating Disorder Awareness week, the latest AHA People Matter, Words Matter poster encourages compassionate and caring language when…